Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Non Invasive Neurostimulation Devices Market From 2025 To 2034?
The non invasive neurostimulation devices market has demonstrated rapid expansion in recent years. It is anticipated to grow from $1.67 billion in 2024 to $1.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.1%. This historical growth can be linked to the increasing occurrence of neurological disorders, enhanced awareness of neurostimulation therapies, a rising need for non-invasive treatments, the expansion of healthcare infrastructure, and increased research in neuromodulation.
The non invasive neurostimulation devices market is anticipated to experience substantial expansion in the coming years. This market is projected to reach a size of $3.06 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.8%. Key factors driving this growth during the forecast period include an aging global population, the increasing integration of wearable neurostimulation devices, heightened spending on healthcare, favorable governmental policies, and broader applications within mental health therapies. Significant trends anticipated for the forecast timeframe encompass a move towards less invasive neurostimulation techniques, advancements in wireless neurostimulation technologies, the broadened use of telehealth, the introduction of closed-loop neurostimulation systems, and an increased emphasis on individualized patient neurostimulation treatments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24625&type=smp
What Are The Key Drivers Of Growth In The Non Invasive Neurostimulation Devices Market?
The expanding occurrence of neurological disorders is anticipated to drive the non invasive neurostimulation devices market growth in the future. These medical conditions affect the brain, spinal cord, and nerves, leading to various symptoms such as cognitive, motor, and sensory impairments. The rising prevalence of neurological disorders is linked to the global aging population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, all contributing to the development and progression of these conditions. Non-invasive neurostimulation devices help in diagnosing neurological disorders by delivering targeted stimulation to assess neural responses. They offer non-surgical, real-time evaluation methods, thereby enhancing diagnostic accuracy and improving patient care in clinical and home settings. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Consequently, the increasing prevalence of neurological disorders is fueling the expansion of the non invasive neurostimulation devices market.
What Are The Primary Types Of Segments Analyzed In The Non Invasive Neurostimulation Devices Market?
The non invasive neurostimulation devices market covered in this report is segmented –
1) By Type Of Stimulation Technology: Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Electromagnetic Stimulation (EMS), Other Types Of Stimulation Technologies
2) By Target Indication: Pain Management, Neurological Disorders, Psychological Disorder, Other Target Indications
3) By End User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes
Subsegments:
1) By Transcutaneous Electrical Nerve Stimulation (TENS): Conventional Transcutaneous Electrical Nerve Stimulation (TENS), Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (TENS), Brief-Intense Transcutaneous Electrical Nerve Stimulation (TENS), Burst Mode Transcutaneous Electrical Nerve Stimulation (TENS)
2) By Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS), Deep Transcranial Magnetic Stimulation (dTMS), Single-Pulse Transcranial Magnetic Stimulation, Paired-Pulse Transcranial Magnetic Stimulation
3) By Electromagnetic Stimulation (EMS): Functional Electromagnetic Stimulation (EMS), Neuromuscular Electromagnetic Stimulation (EMS), High-Frequency Electromagnetic Stimulation (EMS), Low-Frequency Electromagnetic Stimulation (EMS)
4) By Other Types Of Stimulation Technology: Transcranial Direct Current Stimulation (tDCS), Vagus Nerve Stimulation, Cranial Electrotherapy Stimulation (CES), Peripheral Nerve Stimulation (PNS)
What Key Innovation Trends Are Fueling Advancements In The Non Invasive Neurostimulation Devices Market?
Leading companies within the non-invasive neurostimulation devices market are concentrating on creating advanced products, such as personalized stimulation protocols, to bolster treatment effectiveness and enhance patient outcomes. Personalized stimulation protocols describe neurostimulation settings meticulously tailored to an individual’s specific medical condition, neural response, and treatment objectives, with the aim of maximizing therapeutic efficacy and minimizing adverse reactions. For instance, in October 2023, Sooma Medical, a Finland-based medical technology company, unveiled a remote clinician-monitored brain stimulation system developed for at-home treatment using non-invasive transcranial direct current stimulation (tDCS). This innovative system empowers healthcare professionals to remotely supervise therapy sessions, thereby improving accessibility and adherence for patients dealing with neurological and mental health conditions like depression and chronic pain.
Who Are The Primary Competitors In The Global Non Invasive Neurostimulation Devices Market?
Major companies operating in the non invasive neurostimulation devices market are Boston Scientific Corporation, Alpha-Stim, Neurosoft Bioelectronics SA, Neuronetics Inc., BrainsWay Ltd., eNeura Inc., MagVenture A/S, Nexstim Plc, Neuroelectrics Barcelona S.L.U., Cefaly Technology, ElectroCore Inc., Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc., Sooma Medical, Aleva Neurotherapeutics SA, NeuroSigma Inc., Mind Alive Inc., TheBrainDriver LLC, Caputron Medical Products LLC.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Non Invasive Neurostimulation Devices Market During The Forecast Period?
North America was the largest region in the non invasive neurostimulation devices market in 2024. The regions covered in the non invasive neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Non Invasive Neurostimulation Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24625&type=smp
Browse Through More Reports Similar to the Global Non Invasive Neurostimulation Devices Market 2025, By The Business Research Company
Electrical Stimulation Devices Global Market Report 2025
Implantable Neurostimulation Devices Global Market Report 2025
Internal Neuromodulation Devices Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model